Search | IOVS | ARVO Journals

Showing 1 – 20 of 233

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Retina June 2024

Perimacular Atrophy Following Voretigene Neparvovec-Rzyl Treatment in the Setting of Previous Contralateral Eye Treatment With a Different Viral Vector

PDF

Cristy A. Ku; Austin D. Igelman; Samuel J. Huang; Steven T. Bailey; Andreas K. Lauer; Jacque L. Duncan; Richard G. Weleber; Paul Yang; Mark E. Pennesi
TAGS: atrophy, chorioretinal atrophy, eye, genes, viral vector, voretigene neparvovec, visual fields
Trans. Vis. Sci. Tech.. 2024; 13(6):11. https://doi.org/10.1167/tvst.13.6.11

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2024

Effects of Eye Bank Donor Age Expansion on Corneal Endothelial Cell Density and Surgeon Tissue Acceptance

Ayobami Adebayo; Andrea Nortey; Jee-young Moon; Patrick Gore; Tina Livesay; Ronald Bortzfield; Richard Gibralter; Roy S Chuck

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3661.

ARVO Annual Meeting Abstract June 2024

A 96-week PULSAR subgroup analysis: Similar visual and anatomic improvements with aflibercept 8 mg every 12 weeks or longer and 2 mg every 8 weeks, as defined by baseline BCVA, CRT, CNV type, and race

Richard Gale; Oliver Zeitz; Sobha Sivaprasad; Sergio Leal; Tobias Machewitz; xin Zhang

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4906.

ARVO Annual Meeting Abstract June 2024

YorkMac: A binary classification, deep learning convolutional neural network detecting active neovascular age-related macular degeneration; comparing YorkMac and AutoML

Archana Airody; Rachel Hanson; David Hanson; Christine O'Dwyer; Amelia White; Sean Burns; Mia Porteous; Pearse Andrew Keane; Konstantinos Balaskas; Richard Gale

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2328.

ARVO Annual Meeting Abstract June 2024

Real-world treatment patterns and outcomes in the first 6 and 12 months of faricimab use among eyes with neovascular age-related macular degeneration (nAMD) in the UK: FARWIDE-nAMD

Deepali Varma; James Talks; Gabriella de Salvo; Praveen J Patel; Samantha R De Silva; Richard Gale; Martin McKibbin; Gloria Chi; Natalee James; Alice Rothwell; Neil Shah; Amanda Downey; Melanie Dodds; Parul Dayal

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4905.

ARVO Annual Meeting Abstract June 2023

Demographics and Microbiological Profile Associated with Corneal Ulcers Treated at a Tertiary Care Center in the Bronx, New York

Behram Khan; Sruthi Kodali; Amanda Zong; Jee Young Moon; Anurag Shrivastava; Johanna Daily; Richard Gibralter

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):OD28.

ARVO Annual Meeting Abstract June 2023

Predictive value of Preferential Hyperacuity Perimetry in identifying patients at high risk of conversion to neovascular AMD

Michael J Elman; Sidney A Schechet; Shivani Reddy; Richard Garfinkel; Byron Ladd; Alan L. Wagner; George Sanborn; Jennifer Jacobs; Miguel Busquets; Emily Y. Chew

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2737.

ARVO Annual Meeting Abstract June 2023

Cross-sectional study to evaluate the Notal Vision Home OCT (NVHO) for self-imaging and fluid quantification in eyes with Diabetic Macular Edema (DME)

Shelley Joy Levy; Jordana Goren Fein; Richard Garfinkel; Michael J Elman; Sidney A Schechet; Kapil G Kapoor; Alan L. Wagner; Shiri Shulman

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1126.

ARVO Annual Meeting Abstract June 2023

Investigating nAMD and DME treatment burden on recipients and caregivers in the US

Arjun Watane; David Tabano; Oliver Cox; Vincent Garmo; Sarah Hill; Louise Longworth; Yemi Oluboyede; Richard Gale; Nimesh A. Patel

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4196.

Retina April 2023

Improved Rod Sensitivity as Assessed by Two-Color Dark-Adapted Perimetry in Patients With RPE65 -Related Retinopathy Treated With Voretigene Neparvovec-rzyl

PDF

Cristy A. Ku; Austin D. Igelman; Samuel J. Huang; Huber Vasconcelos; Mariana Matioli da Palma; Steven T. Bailey; Andreas K. Lauer; Richard G. Weleber; Paul Yang; Mark E. Pennesi
TAGS: color, perimetry, retinal diseases, rod photoreceptors, rpe65 protein, voretigene neparvovec, vision
Trans. Vis. Sci. Tech.. 2023; 12(4):17. https://doi.org/10.1167/tvst.12.4.17

Includes: Multimedia, Supplemental Content

Article October 2022

Visual stream connectivity predicts assessments of image quality

PDF

Elijah F. W. Bowen; Antonio M. Rodriguez; Damian R. Sowinski; Richard Granger
TAGS: datasets, image quality, perception, pixel, psychophysics, judgment
Journal of Vision. 2022; 22(11):4. https://doi.org/10.1167/jov.22.11.4

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2022

Retinal Characterization of Sphingosine-1-Phosphate Receptor 2 Knockout Mice

Richard Grambergs; Abhishek P. Shrestha; Koushik Mondal; TJ Hollingsworth; David M. Sherry; Thirumalani Vaithianathan; Nawajes A Mandal

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1911 – A0057.

ARVO Annual Meeting Abstract June 2022

Effects of Iris Pigmentation on Degree of Anterior Chamber Inflammation after Cataract Surgery using Automated Analysis by Spectral Domain Optical Coherence Tomography

Naveen Karthik; Sumit Sharma; Richard Gans; Kimberly Baynes; Emily Fisher; Cindy Chen; Peter K Kaiser; Arthi Venkat; Careen Y. Lowder; Sunil K Srivastava

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3348 – F0157.

ARVO Annual Meeting Abstract June 2022

EPDev-AI: Early phase development of an AI tool to determine disease activity in nvAMD

Rachel L.W. Hanson; Archana Airody; Christine O'Dwyer; Amelia White; Mia Porteous; Richard P Gale

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):209 – F0056.

ARVO Annual Meeting Abstract June 2022

ATHENA Study Protocol - Optical Coherence Tomography Angiography Analysis for the detection of Neovascular Age-related Macular Degeneration: a Comprehensive Multi-Centre, Prospective, Randomised Diagnostic Accuracy and Non-Inferiority Study

Magdalena Niestrata; Pearse Andrew Keane; Praveen Patel; Sobha Sivaprasad; Tunde Peto; Savita Madhusudhan; Alastair K Denniston; Richard P Gale; Konstantinos Balaskas

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2902 – F0055.

ARVO Annual Meeting Abstract June 2022

Analysis of the Long-term visual Outcomes of ForeseeHome Remote Telemonitoring - The ALOFT study

Mariam Mathai; Shivani Reddy; Michael J Elman; Richard A. Garfinkel; Byron Ladd; Alan Wagner; George E. Sanborn; Jennifer Jacobs; Miguel Busquets

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):383 – F0214.

Visual Neuroscience May 2022

Cortical Atrophy Predicts Visual Performance in Long-Term Central Retinal Disease; GCL, pRNFL and Cortical Thickness Are Key Biomarkers

PDF

Rachel L. W. Hanson; Heidi A. Baseler; Archana Airody; Antony B. Morland; Richard P. Gale
TAGS: biological markers, cerebral atrophy, eye, retinal diseases, visual pathways, retina, anti-vascular endothelial growth factor therapy, volume
Invest. Ophthalmol. Vis. Sci.. 2022; 63(5):35. https://doi.org/10.1167/iovs.63.5.35

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2021

Systemic Antisense Oligonucleotide Inhibition of Complement Factor B for Treatment of Geographic Atrophy: Results of a Placebo-controlled Phase 1 Dose-Escalation Study

David S Boyer; Jayashree Sahni; Sascha Fauser; Richard Geary; Eugene Schneider; Michael McCaleb

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):196.

ARVO Annual Meeting Abstract June 2021

Cytoprotective Effects of Brimonidine in an Induced Pluripotent Stem Cell (iPSC)-Derived Retinal Pigment Epithelium (RPE) Model of Age-Related Macular Degeneration (AMD)

Lori-Ann Christie; Ruchi Sharma; Malika Nimmagadda; Davide Ortolan; Genqing Liang; Kiyoharu Joshua Miyagishima; Mitalee Tamhane; Mike Ly; William Change; Richard Graham; Shaoxin Feng; Francisco J Lopez; Brenda Smith; Kapil Bharti

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):195.

Article January 2021

On the contrast dependence of crowding

PDF

Antonio Rodriguez; Richard Granger

Journal of Vision. 2021; 21(1):4. https://doi.org/10.1167/jov.21.1.4

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Filters

Specify Date Range

Perimacular Atrophy Following Voretigene Neparvovec-Rzyl Treatment in the Setting of Previous Contralateral Eye Treatment With a Different Viral Vector

Effects of Eye Bank Donor Age Expansion on Corneal Endothelial Cell Density and Surgeon Tissue Acceptance

A 96-week PULSAR subgroup analysis: Similar visual and anatomic improvements with aflibercept 8 mg every 12 weeks or longer and 2 mg every 8 weeks, as defined by baseline BCVA, CRT, CNV type, and race

YorkMac: A binary classification, deep learning convolutional neural network detecting active neovascular age-related macular degeneration; comparing YorkMac and AutoML

Real-world treatment patterns and outcomes in the first 6 and 12 months of faricimab use among eyes with neovascular age-related macular degeneration (nAMD) in the UK: FARWIDE-nAMD

Demographics and Microbiological Profile Associated with Corneal Ulcers Treated at a Tertiary Care Center in the Bronx, New York

Predictive value of Preferential Hyperacuity Perimetry in identifying patients at high risk of conversion to neovascular AMD

Cross-sectional study to evaluate the Notal Vision Home OCT (NVHO) for self-imaging and fluid quantification in eyes with Diabetic Macular Edema (DME)

Investigating nAMD and DME treatment burden on recipients and caregivers in the US

Improved Rod Sensitivity as Assessed by Two-Color Dark-Adapted Perimetry in Patients With RPE65 -Related Retinopathy Treated With Voretigene Neparvovec-rzyl

Visual stream connectivity predicts assessments of image quality

Retinal Characterization of Sphingosine-1-Phosphate Receptor 2 Knockout Mice

Effects of Iris Pigmentation on Degree of Anterior Chamber Inflammation after Cataract Surgery using Automated Analysis by Spectral Domain Optical Coherence Tomography

EPDev-AI: Early phase development of an AI tool to determine disease activity in nvAMD

ATHENA Study Protocol - Optical Coherence Tomography Angiography Analysis for the detection of Neovascular Age-related Macular Degeneration: a Comprehensive Multi-Centre, Prospective, Randomised Diagnostic Accuracy and Non-Inferiority Study

Analysis of the Long-term visual Outcomes of ForeseeHome Remote Telemonitoring - The ALOFT study

Cortical Atrophy Predicts Visual Performance in Long-Term Central Retinal Disease; GCL, pRNFL and Cortical Thickness Are Key Biomarkers

Systemic Antisense Oligonucleotide Inhibition of Complement Factor B for Treatment of Geographic Atrophy: Results of a Placebo-controlled Phase 1 Dose-Escalation Study

Cytoprotective Effects of Brimonidine in an Induced Pluripotent Stem Cell (iPSC)-Derived Retinal Pigment Epithelium (RPE) Model of Age-Related Macular Degeneration (AMD)

On the contrast dependence of crowding

To View More...

You must be signed into an individual account to use this feature.